XML 56 R9.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

GOODWILL AND OTHER INTANGIBLE ASSETS | 12 Months Ended
--- | ---
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND OTHER INTANGIBLE ASSETS | GOODWILL AND OTHER INTANGIBLE ASSETS Changes in the carrying amount of goodwill follow:
(Dollars in millions) | Additives & Functional Products |  | Advanced Materials |  | Chemical Intermediates |  | Other |  | Total
Balance at December 31, 2017 | $ | 2,459 |  |  | $ | 1,289 |  |  | $ | 769 |  |  | $ | 10 |  |  | $ | 4,527 |
Impairments recognized | (38 | ) |  | — |  |  | — |  |  | — |  |  | (38 | )
Currency translation adjustments | (11 | ) |  | (6 | ) |  | (5 | ) |  | — |  |  | (22 | )
Balance at December 31, 2018 | 2,410 |  |  | 1,283 |  |  | 764 |  |  | 10 |  |  | 4,467 |
Acquisitions | 15 |  |  | — |  |  | — |  |  | — |  |  | 15 |
Impairments recognized | (45 | ) |  | — |  |  | — |  |  | — |  |  | (45 | )
Currency translation adjustments | (3 | ) |  | (1 | ) |  | (2 | ) |  | — |  |  | (6 | )
Balance at December 31, 2019 | $ | 2,377 |  |  | $ | 1,282 |  |  | $ | 762 |  |  | $ | 10 |  |  | $ | 4,431 |
Eastman conducts testing of goodwill annually in the fourth quarter or more frequently when events and circumstances indicate an impairment may have occurred. A reporting unit's goodwill is considered to be impaired when the reporting unit's estimated fair value is less than its carrying value. The Company uses an income approach and applies a discounted cash flow model in testing the carrying value of goodwill for each reporting unit. Key assumptions and estimates used in the Company's 2019 goodwill impairment testing included projections of revenues and EBIT determined using the Company's annual multi-year strategic plan, the estimated WACC, and a projected long-term growth rate. As a result of the goodwill impairment testing performed during fourth quarter 2019, fair values were determined to exceed the carrying values for each reporting unit tested with the exception of crop protection (part of the Additives & Functional Products ("AFP") segment). In fourth quarter 2019 and 2018, as a result of the annual impairment test of goodwill, the Company recognized goodwill impairments of $45 million and $38 million, respectively, in the crop protection reporting unit. The impairment in 2019 was primarily due to the impact of recent regulatory changes in the European Union on current period and forecasted revenue and EBIT and a decrease in the long-term growth rate for the reporting unit assumed in the goodwill impairment model. The impairment in 2018 was primarily due to the WACC applied to the impairment analysis and the estimated impact of future regulatory changes. The crop protection reporting unit's goodwill after the reduction for impairment was $190 million as of December 31, 2019. As of December 31, 2019, the reported balance of goodwill included accumulated impairment losses of $106 million, $12 million, and $14 million in the AFP segment, Chemical Intermediates ("CI") segment, and other segments, respectively. As of December 31, 2018, the reported balance of goodwill included accumulated impairment losses of $61 million, $12 million, and $14 million in the AFP segment, CI segment, and other segments, respectively. The carrying amounts of intangible assets follow:
|  |  |  | December 31, 2019 |  | December 31, 2018
(Dollars in millions) | Estimated Useful Life in Years | Gross Carrying Value |  | Accumulated Amortization |  | Net Carrying Value |  | Gross Carrying Value |  | Accumulated Amortization |  | Net Carrying Value
Amortizable intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Customer relationships | 8 | - | 25 | $ | 1,566 |  |  | $ | 494 |  |  | $ | 1,072 |  |  | $ | 1,567 |  |  | $ | 419 |  |  | $ | 1,148 |
Technology | 7 | - | 20 | 677 |  |  | 343 |  |  | 334 |  |  | 680 |  |  | 294 |  |  | 386 |
Contracts |  | 5 |  | — |  |  | — |  |  | — |  |  | 180 |  |  | 147 |  |  | 33 |
Other | 5 | - | 37 | 88 |  |  | 22 |  |  | 66 |  |  | 102 |  |  | 23 |  |  | 79 |
Indefinite-lived intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tradenames |  |  |  | 529 |  |  | — |  |  | 529 |  |  | 529 |  |  | — |  |  | 529 |
Other |  |  |  | 10 |  |  | — |  |  | 10 |  |  | 10 |  |  | — |  |  | 10 |
Total identified intangible assets |  |  |  | $ | 2,870 |  |  | $ | 859 |  |  | $ | 2,011 |  |  | $ | 3,068 |  |  | $ | 883 |  |  | $ | 2,185 |
Amortization expense of definite-lived intangible assets was $160 million, $164 million, and $164 million for 2019, 2018, and 2017, respectively. Estimated amortization expense for future periods is $130 million in 2020, $125 million in 2021, and $115 million each year for 2022 through 2024.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration